BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18258798)

  • 1. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
    Bluhm EC; Ronckers C; Hayashi RJ; Neglia JP; Mertens AC; Stovall M; Meadows AT; Mitby PA; Whitton JA; Hammond S; Barker JD; Donaldson SS; Robison LL; Inskip PD
    Blood; 2008 Apr; 111(8):4014-21. PubMed ID: 18258798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
    Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
    Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
    Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
    Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
    Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
    J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancy after treatment of childhood non-Hodgkin lymphoma.
    Leung W; Sandlund JT; Hudson MM; Zhou Y; Hancock ML; Zhu Y; Ribeiro RC; Rubnitz JE; Kun LE; Razzouk B; Evans WE; Pui CH
    Cancer; 2001 Oct; 92(7):1959-66. PubMed ID: 11745271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
    Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
    J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
    Smeland KB; Kiserud CE; Lauritzsen GF; Blystad AK; Fagerli UM; Falk RS; Fluge Ø; Fosså A; Kolstad A; Loge JH; Maisenhölder M; Østenstad B; Kvaløy S; Holte H
    Br J Haematol; 2016 May; 173(3):432-43. PubMed ID: 26914167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis.
    Pirani M; Marcheselli R; Marcheselli L; Bari A; Federico M; Sacchi S
    Ann Oncol; 2011 Aug; 22(8):1845-58. PubMed ID: 21310758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
    Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
    Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
    Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
    Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.